• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.11% Nasdaq Up 0.31%

    Advaxis, Inc. (ADXS)

    -NasdaqCM
    9.12 Up 0.30(3.40%) Jan 18, 4:00PM EST
    |Pre-Market : 9.12 0.00 (0.00%) 4:48PM EST - Nasdaq Real Time Price
    Prev Close:8.82
    Open:N/A
    Bid:7.99 x 1800
    Ask:9.74 x 100
    1y Target Est:22.00
    Beta:2.24568
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:5.21 - 16.30
    Volume:0
    Avg Vol (3m):726,311
    Market Cap:363.38M
    P/E (ttm):N/A
    EPS (ttm):-2.08
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ADXS

    Comparison

    Symbol% ChgMkt Cap
    ADXSUp 3.40%363.38M
    VICLDown 2.58%25.08M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):88.64
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Oct-17) :-2.01
    Quarterly EPS Est (Jan-17) :-0.54
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback